{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:56Z","timestamp":1792270976619,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Almost half of all colorectal cancer (CRC) patients will experience metastases at some point, and in the majority of cases, multiple organs will be involved. If the peritoneum is involved in addition to the liver, the current guideline-driven treatment options are limited. The reported overall survival ranges from 6 to 13 months for the current standard of care (systemic treatment). This study aimed to evaluate morbidity and clinical long-term outcomes from a combined local treatment of hepatic metastases with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) used to treat peritoneal metastases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search was performed in PubMed, Embase.com, Web of Science, and Cochrane. Studies evaluating the clinicopathologic data of patients who had both peritoneal and hepatic metastases treated with CRS-HIPEC were included provided sufficient data on the primary outcomes (overall and disease-free survival) were presented. The quality of included studies was assessed using the Methodological Index for Non-Randomized Studies (MINORS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients treated for peritoneal and liver metastases (PMLM group) had a pooled mean survival of 26.4 months (95% confidence interval [CI] 22.4\u201330.4 months), with a 3-year survival rate of 34% (95% CI 26.7\u201342.0%) and a 5-year survival rate of 25% (95% CI 17.3\u201333.8%). Surgical complications occurred more frequently for these patients than for those with peritoneal metastasis only (40% vs 22%; <jats:italic>p<\/jats:italic> = 0.0014), but the mortality and reoperation rates did not differ significantly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This systematic review showed that CRS and HIPEC combined with local treatment of limited liver metastasis for selected patients is feasible, although with increased morbidity and an association with a long-term survival rate of 25%, which is unlikely to be achievable with systemic treatment only.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-021-10925-y","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T16:06:08Z","timestamp":1634918768000},"page":"1952-1962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Outcomes of Combined Peritoneal and Local Treatment for Patients with Peritoneal and Limited Liver Metastases of Colorectal Origin: A Systematic Review and Meta-Analysis"],"prefix":"10.1245","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-4098","authenticated-orcid":false,"given":"Margot C. E.","family":"Polderdijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.","family":"Ziesemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Boerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels F. M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathelijn S.","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirkje W.","family":"Sommeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurriaan B.","family":"Tuynman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"10925_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"10925_CR2","unstructured":"SEER Cancer Stat Facts: Colorectal Cancer. National Cancer Institute. Retrieved 2 April 2021 at https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html."},{"key":"10925_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/ajco.13420","volume":"17","author":"A Kuchel","year":"2021","unstructured":"Kuchel A, Ahern E, Collins S, et al. Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study. Asia Pac J Clin Oncol. 2021;17:84\u201393.","journal-title":"Asia Pac J Clin Oncol."},{"key":"10925_CR4","doi-asserted-by":"publisher","first-page":"29765","DOI":"10.1038\/srep29765","volume":"6","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.","journal-title":"Sci Rep."},{"key":"10925_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG van der Geest","year":"2015","unstructured":"van der Geest LG, Lam-Boer J, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment, and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32:457\u201365.","journal-title":"Clin Exp Metastasis."},{"key":"10925_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.soc.2017.11.010","volume":"27","author":"J Chakedis","year":"2018","unstructured":"Chakedis J, Schmidt CR. Surgical treatment of metastatic colorectal cancer. Surg Oncol Clin North Am. 2018;27:377\u201399.","journal-title":"Surg Oncol Clin North Am."},{"key":"10925_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.21037\/jtd.2016.05.98","volume":"8","author":"F Guerrera","year":"2016","unstructured":"Guerrera F, Mossetti C, Ceccarelli M, et al. Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery. J Thorac Dis. 2016;8:1764\u201371.","journal-title":"J Thorac Dis."},{"key":"10925_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2482-10-27","volume":"10","author":"M Hayashi","year":"2010","unstructured":"Hayashi M, Inoue Y, Komeda K, et al. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg. 2010;10:1\u201312.","journal-title":"BMC Surg."},{"key":"10925_CR9","doi-asserted-by":"publisher","first-page":"36566","DOI":"10.18632\/oncotarget.16616","volume":"8","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Park IJ, Kim HR, et al. Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancer. Oncotarget. 2017;8:36566\u201377.","journal-title":"Oncotarget."},{"key":"10925_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ans.14933","volume":"89","author":"H Shin","year":"2019","unstructured":"Shin H, Kim CW, Lee JL, et al. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival. ANZ J Surg. 2019;89:61\u20137.","journal-title":"ANZ J Surg."},{"key":"10925_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","volume":"42","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, Razenberg LG, Lemmens VE, Rutten HJ, Creemers G-J, de Hingh IH. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases. Eur J Surg Oncol. 2016;42:794\u2013800.","journal-title":"Eur J Surg Oncol."},{"key":"10925_CR12","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol."},{"key":"10925_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3:585\u201394.","journal-title":"BJS Open."},{"key":"10925_CR14","first-page":"310","volume":"18","author":"M Flood","year":"2021","unstructured":"Flood M, Narasimhan V, Waters P, et al. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review and discussion of latest controversies. Surgeon. 2021;18:310\u201320.","journal-title":"for."},{"key":"10925_CR15","unstructured":"Landelijke Werkgroep Gastro Intestinale Tumoren. Colorectaalcarcinoom: Landelijke richtlijn. 2019."},{"key":"10925_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Soc Surg Oncol Ann Surg Oncol. 2007;14:128\u201333.","journal-title":"Soc Surg Oncol Ann Surg Oncol."},{"key":"10925_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med."},{"key":"10925_CR18","unstructured":"Otten R, de Vries R, Schoonmade L. Amsterdam Efficient Deduplication (AED) method. 2019."},{"key":"10925_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104:240\u20133.","journal-title":"J Med Libr Assoc."},{"key":"10925_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712\u20136.","journal-title":"ANZ J Surg."},{"key":"10925_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Method. 2014;14:135.","journal-title":"BMC Med Res Method."},{"key":"10925_CR22","unstructured":"R: A Language and Environment for Statistical Computing (computer program). R Foundation for Statistical Computing, Vienna, Austria, 2021."},{"key":"10925_CR23","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1245\/s10434-020-09165-3","volume":"28","author":"M Adileh","year":"2021","unstructured":"Adileh M, Mor E, Assaf D, et al. Perioperative and oncological outcomes of combined hepatectomy with complete cytoreduction and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Ann Surg Oncol. 2021;28:3320\u201329.","journal-title":"Ann Surg Oncol."},{"key":"10925_CR24","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1111\/ans.13231","volume":"87","author":"N Alzahrani","year":"2017","unstructured":"Alzahrani N, Ung L, Valle SJ, Liauw W, Morris DL. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. ANZ J Surg. 2017;87:E167\u201372.","journal-title":"ANZ J Surg."},{"key":"10925_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/DCR.0000000000001156","volume":"61","author":"D Baratti","year":"2018","unstructured":"Baratti D, Kusamura S, Iusco D, et al. Should a history of extraperitoneal disease be a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer peritoneal metastases? Dis Colon Rectum. 2018;61:1026\u201334.","journal-title":"Dis Colon Rectum."},{"key":"10925_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/jso.24153","volume":"113","author":"Y Berger","year":"2016","unstructured":"Berger Y, Aycart S, Tabrizian P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement. J Surg Oncol. 2016;113:432\u20137.","journal-title":"J Surg Oncol."},{"key":"10925_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijsu.2015.11.025","volume":"25","author":"JB Delhorme","year":"2016","unstructured":"Delhorme JB, Dupont-Kazma L, Addeo P, et al. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: who will benefit from complete cytoreductive surgery? Int J Surg. 2016;25:98\u2013105.","journal-title":"Int J Surg."},{"key":"10925_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jss.2017.05.126","volume":"219","author":"S Downs-Canner","year":"2017","unstructured":"Downs-Canner S, Shuai Y, Ramalingam L, et al. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res. 2017;219:194\u2013201.","journal-title":"J Surg Res."},{"key":"10925_CR29","first-page":"388","volume":"4","author":"FF Duraj","year":"2013","unstructured":"Duraj FF, Cashin PH. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study. J Gastrointest Oncol. 2013;4:388\u201396.","journal-title":"J Gastrointest Oncol."},{"key":"10925_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jviscsurg.2019.06.007","volume":"156","author":"P Horvath","year":"2019","unstructured":"Horvath P, Beckert S, K\u00f6nigsrainer A, Nadalin S, K\u00f6nigsrainer I. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors. J Visc Surg. 2019;156:475\u201384.","journal-title":"J Visc Surg."},{"key":"10925_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12957-019-1746-x","volume":"17","author":"Y Jeon","year":"2019","unstructured":"Jeon Y, Park EJ, Lim JH, Baik SH. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer. World J Surg Oncol. 2019;17:214.","journal-title":"World J Surg Oncol."},{"key":"10925_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.sla.0000255561.87771.11","volume":"245","author":"R Kianmanesh","year":"2007","unstructured":"Kianmanesh R, Scaringi S, Sabate JM, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597\u2013603.","journal-title":"Ann Surg."},{"key":"10925_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jso.26239","volume":"123","author":"RM Lee","year":"2021","unstructured":"Lee RM, Gamboa AC, Turgeon MK, et al. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery\/HIPEC. J Surg Oncol. 2021;123:187\u201395.","journal-title":"J Surg Oncol."},{"key":"10925_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2020.07.038","volume":"47","author":"R Lo Dico","year":"2021","unstructured":"Lo Dico R, Faron M, Yonemura Y, et al. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021;47:89\u2013100.","journal-title":"Eur J Surg Oncol."},{"key":"10925_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","volume":"43","author":"G Lorimier","year":"2017","unstructured":"Lorimier G, Linot B, Paillocher N, et al. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Eur J Surg Oncol. 2017;43:150\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"10925_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/SLA.0b013e3182778089","volume":"258","author":"L Maggiori","year":"2013","unstructured":"Maggiori L, Goere D, Viana B, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258:116\u201321.","journal-title":"Ann Surg."},{"key":"10925_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ciresp.2017.03.003","volume":"95","author":"R Morales Soriano","year":"2017","unstructured":"Morales Soriano R, Mor\u00f3n Canis JM, Molina Romero X, et al. Influence of simultaneous liver and peritoneal resection on postoperative morbi-mortality and survival in patients with colon cancer treated with surgical cytoreduction and intraperitoneal hyperthermic chemotherapy. Cir Esp. 2017;95:214\u201321.","journal-title":"Cir Esp."},{"key":"10925_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.21037\/jgo.2018.06.04","volume":"9","author":"TJ Mouw","year":"2018","unstructured":"Mouw TJ, Lu J, Woody-Fowler M, et al. Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery\/hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). J Gastrointest Oncol. 2018;9:828\u201332.","journal-title":"J Gastrointest Oncol."},{"key":"10925_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1245\/s10434-016-5543-2","volume":"23","author":"J Navez","year":"2016","unstructured":"Navez J, Remue C, Leonard D, et al. Surgical treatment of colorectal cancer with peritoneal and liver metastases using combined liver and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: report from a single-centre experience. Ann Surg Oncol. 2016;23:666\u201373.","journal-title":"Ann Surg Oncol."},{"key":"10925_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00423-019-01787-w","volume":"404","author":"A Pinto","year":"2019","unstructured":"Pinto A, Hobeika C, Philis A, Kirzin S, Carr\u00e8re N, Ghouti L. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbecks Arch Surg. 2019;404:477\u201388.","journal-title":"Langenbecks Arch Surg."},{"key":"10925_CR41","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1245\/s10434-014-3987-9","volume":"22","author":"RW Randle","year":"2015","unstructured":"Randle RW, Doud AN, Levine EA, et al. Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015;22:1634\u20138.","journal-title":"Ann Surg Oncol."},{"key":"10925_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jso.24543","volume":"115","author":"A Saxena","year":"2017","unstructured":"Saxena A, Valle SJ, Liauw W, Morris DL. Limited synchronous hepatic resection does not compromise perioperative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;115:417\u201324.","journal-title":"J Surg Oncol."},{"key":"10925_CR43","doi-asserted-by":"crossref","unstructured":"Pelz JOW, Chua TC, Esquivel J, et al. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10.","DOI":"10.1186\/1471-2407-10-689"},{"key":"10925_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejca.2016.07.002","volume":"65","author":"LGEM Razenberg","year":"2016","unstructured":"Razenberg LGEM, Lemmens VEPP, Verwaal VJ, et al. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study. Eur J Cancer. 2016;65:113\u201320.","journal-title":"Eur J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10925-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:06:47Z","timestamp":1643821607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10925-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10925"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10925-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}